Granules India Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

Granules India announced the successful closing of the acquisition of Senn Chemicals AG, a Swiss based Contract Development and Manufacturing Organization (CDMO) specializing in peptide development and manufacturing. This marks a strategic milestone in Granules' transformation into a science- and innovation-led organization and extends its capabilities into the fast growing peptide therapeutics segment.

The acquisition follows the signing of a definitive share purchase agreement in February 2025, under which Granules, through its wholly owned Indian subsidiary, Granules Peptides, acquired 100% of the equity of Senn Chemicals from the founding Senn family.

Founded over 60 years ago, Senn Chemicals has built a strong reputation as a specialist in Liquid-Phase Peptide Synthesis (LPPS) and Solid-Phase Peptide Synthesis (SPPS), serving innovators and brand owners across pharmaceutical, cosmetic, amino acid derivative (AAD), and theragnostic markets.

Powered by Capital Market - Live News

Granules India has allotted 50,000 equity shares under ESOS on 20 March 2025.

Powered by Capital Market - Live News

Granules India Ltd lost 3.02% today to trade at Rs 457.2. The BSE Healthcare index is down 0.24% to quote at 38485.45. The index is down 8.14 % over last one month. Among the other constituents of the index, Indoco Remedies Ltd decreased 2.87% and Sun Pharma Advanced Research Company Ltd lost 2.45% on the day. The BSE Healthcare index went up 10.88 % over last one year compared to the 0.67% fall in benchmark SENSEX.

Granules India Ltd has lost 17.88% over last one month compared to 8.14% fall in BSE Healthcare index and 5.19% drop in the SENSEX. On the BSE, 4363 shares were traded in the counter so far compared with average daily volumes of 45200 shares in the past one month. The stock hit a record high of Rs 724.55 on 02 Sep 2024. The stock hit a 52-week low of Rs 382.05 on 15 Apr 2024.

Powered by Capital Market - Live News

Granules India has allotted 50,000 equity shares under ESOS on 20 March 2025.

Powered by Capital Market - Live News

Granules India Ltd lost 3.02% today to trade at Rs 457.2. The BSE Healthcare index is down 0.24% to quote at 38485.45. The index is down 8.14 % over last one month. Among the other constituents of the index, Indoco Remedies Ltd decreased 2.87% and Sun Pharma Advanced Research Company Ltd lost 2.45% on the day. The BSE Healthcare index went up 10.88 % over last one year compared to the 0.67% fall in benchmark SENSEX.

Granules India Ltd has lost 17.88% over last one month compared to 8.14% fall in BSE Healthcare index and 5.19% drop in the SENSEX. On the BSE, 4363 shares were traded in the counter so far compared with average daily volumes of 45200 shares in the past one month. The stock hit a record high of Rs 724.55 on 02 Sep 2024. The stock hit a 52-week low of Rs 382.05 on 15 Apr 2024.

Powered by Capital Market - Live News

Granules India announced that Sethu Madhavan Sankaran, shall cease to be the Senior Management Personnel (SMP) of the Company upon his resignation from the position of Senior Vice President & Head- API Manufacturing & Operations with effect from the closure of business hours of 28 February 2025.

Powered by Capital Market - Live News

Granules India announced the successful closing of the acquisition of Senn Chemicals AG, a Swiss based Contract Development and Manufacturing Organization (CDMO) specializing in peptide development and manufacturing. This marks a strategic milestone in Granules' transformation into a science- and innovation-led organization and extends its capabilities into the fast growing peptide therapeutics segment.

The acquisition follows the signing of a definitive share purchase agreement in February 2025, under which Granules, through its wholly owned Indian subsidiary, Granules Peptides, acquired 100% of the equity of Senn Chemicals from the founding Senn family.

Founded over 60 years ago, Senn Chemicals has built a strong reputation as a specialist in Liquid-Phase Peptide Synthesis (LPPS) and Solid-Phase Peptide Synthesis (SPPS), serving innovators and brand owners across pharmaceutical, cosmetic, amino acid derivative (AAD), and theragnostic markets.

Powered by Capital Market - Live News

Granules India has allotted 50,000 equity shares under ESOS on 20 March 2025.

Powered by Capital Market - Live News

Granules India Ltd lost 3.02% today to trade at Rs 457.2. The BSE Healthcare index is down 0.24% to quote at 38485.45. The index is down 8.14 % over last one month. Among the other constituents of the index, Indoco Remedies Ltd decreased 2.87% and Sun Pharma Advanced Research Company Ltd lost 2.45% on the day. The BSE Healthcare index went up 10.88 % over last one year compared to the 0.67% fall in benchmark SENSEX.

Granules India Ltd has lost 17.88% over last one month compared to 8.14% fall in BSE Healthcare index and 5.19% drop in the SENSEX. On the BSE, 4363 shares were traded in the counter so far compared with average daily volumes of 45200 shares in the past one month. The stock hit a record high of Rs 724.55 on 02 Sep 2024. The stock hit a 52-week low of Rs 382.05 on 15 Apr 2024.

Powered by Capital Market - Live News

Granules India has allotted 50,000 equity shares under ESOS on 20 March 2025.

Powered by Capital Market - Live News

Granules India Ltd lost 3.02% today to trade at Rs 457.2. The BSE Healthcare index is down 0.24% to quote at 38485.45. The index is down 8.14 % over last one month. Among the other constituents of the index, Indoco Remedies Ltd decreased 2.87% and Sun Pharma Advanced Research Company Ltd lost 2.45% on the day. The BSE Healthcare index went up 10.88 % over last one year compared to the 0.67% fall in benchmark SENSEX.

Granules India Ltd has lost 17.88% over last one month compared to 8.14% fall in BSE Healthcare index and 5.19% drop in the SENSEX. On the BSE, 4363 shares were traded in the counter so far compared with average daily volumes of 45200 shares in the past one month. The stock hit a record high of Rs 724.55 on 02 Sep 2024. The stock hit a 52-week low of Rs 382.05 on 15 Apr 2024.

Powered by Capital Market - Live News

Granules India announced that Sethu Madhavan Sankaran, shall cease to be the Senior Management Personnel (SMP) of the Company upon his resignation from the position of Senior Vice President & Head- API Manufacturing & Operations with effect from the closure of business hours of 28 February 2025.

Powered by Capital Market - Live News